IMMUNEERING CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.38 USD | -3.50% |
|
-6.76% | -81.22% |
Chart calendar Immuneering Corporation
d318f1af982725d15e631a9a1c9ff146.P2_4rzwfwnOcTV6owmvulQ_KwtQD2z3bY5EKc9l3oLA.DRi94QlZsRfqOXPmsSqez12QpJlng3KCB9g_HuAf1PRVCIDganOOCdsKDw~ea8e094a8df5039b08ef16fed163f0d0
Upcoming events on Immuneering Corporation
Past events on Immuneering Corporation
| 12/06/2024 08:30 pm | Annual General Meeting |
| 06/06/2024 02:00 am | Jefferies Global Healthcare Conference |
| 08/05/2024 01:35 am | Q1 2024 Earnings Release |
| 12/04/2024 12:30 am | Needham Healthcare Conference |
| 09/04/2024 09:30 pm | American Association for Cancer Research Meeting - Abstract No: 4195 |
| 14/03/2024 06:00 pm | Business Update Call |
| 05/03/2024 11:20 pm | TD Cowen Health Care Conference |
| 01/03/2024 06:30 pm | Q4 2023 Earnings Release |
| 14/02/2024 01:50 am | Oppenheimer Healthcare Life Sciences Conference |
| 07/02/2024 11:30 pm | Guggenheim Healthcare Talks Biotechnology Conference |
| 30/11/2023 10:00 pm | Piper Sandler Healthcare Conference |
| 10/11/2023 02:35 am | Q3 2023 Earnings Release |
| 12/10/2023 10:00 pm | AACR-NCI-EORTC International Conference - Abstract number: A093 |
| 12/10/2023 10:00 pm | AACR-NCI-EORTC International Conference - Abstract number : A134 |
| 13/09/2023 07:40 pm | Morgan Stanley Global Healthcare Conference |
| 04/08/2023 01:35 am | Q2 2023 Earnings Release |
| 14/06/2023 08:30 pm | Annual General Meeting |
| 08/06/2023 07:30 pm | Jefferies Global Healthcare Conference |
| 05/05/2023 01:35 am | Q1 2023 Earnings Release |
| 19/04/2023 10:15 pm | Needham Healthcare Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 2,08 2,44 -14.91% | 0,32 0,42 -24.74% | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -33,8 -34,0 0.61% | -51,5 -52,1 1.23% | -58,1 -58,2 0.17% | -72,2 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -33,9 -32,4 -4.55% | -51,7 -53,2 2.77% | -58,4 -57,3 -1.92% | -71,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -33,8 -32,3 -4.7% | -50,5 -52,7 4.2% | -53,5 -52,5 -1.86% | -67,8 |
|
Net income Million USD | Released Forecast Spread | -17,0 | -33,5 -32,3 -3.75% | -50,5 -52,7 4.2% | -53,5 -52,5 -1.86% | -67,8 |
|
EPS USD | Released Forecast Spread | -4,82 | -2,46 -3,52 30.16% | -1,91 -2,00 4.26% | -1,88 -1,83 -2.52% | -1,97 |
| Announcement Date | 13/05/21 | 10/03/22 | 06/03/23 | 01/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,18 0,18 0.93% | 0,09 0,18 -46.75% | 0,04 0,15 -74.8% | 0,00 0,05 -99.08% | 0,00 0,01 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -12,9 -11,9 -8.65% | -11,6 -13,9 15.91% | -13,2 -13,2 0.11% | -14,0 -15,7 10.66% | -14,7 -14,8 0.68% | -13,5 -15,5 12.67% | -13,9 -15,0 7.09% | -16,3 -15,0 -8.45% | -15,3 -17,5 12.56% | -17,1 | -18,3 | -20,3 | -18,8 | -19,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -12,9 -11,8 -9.4% | -11,5 -13,7 15.67% | -12,8 -13,1 1.84% | -13,2 -15,5 14.37% | -13,6 -14,5 6.03% | -12,2 -15,0 18.58% | -12,6 -14,3 11.79% | -15,1 -14,1 -6.88% | -14,3 -16,7 14.13% | -16,3 | -17,6 | -19,4 | -17,8 | -18,9 |
|
Net income Million USD | Released Forecast Spread | -12,9 -11,8 -9.4% | -11,5 -13,7 15.67% | -12,8 -13,1 1.84% | -13,2 -15,5 14.37% | -13,6 -14,5 6.03% | -12,2 -15,0 18.58% | -12,6 -14,3 11.79% | -15,1 -14,1 -6.88% | -14,3 -16,6 13.79% | -16,3 | -17,6 | -19,4 | -17,8 | -18,9 |
|
EPS USD | Released Forecast Spread | -0,49 -0,45 -8.89% | -0,44 -0,52 15.38% | -0,49 -0,49 0% | -0,50 -0,58 14.04% | -0,51 -0,55 6.42% | -0,43 -0,51 16.39% | -0,43 -0,49 11.94% | -0,52 -0,46 -12.43% | -0,49 -0,51 2.97% | -0,53 | -0,54 | -0,46 | -0,41 | -0,35 |
| Announcement Date | 10/05/22 | 10/08/22 | 10/11/22 | 06/03/23 | 04/05/23 | 03/08/23 | 09/11/23 | 01/03/24 | 07/05/24 | - | - | - | - | - |
| 15/07/2024 11:15 am | ADDLIFE AB: Q2 2024 Earnings Release |
| 22/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 24/07/2024 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 25/07/2024 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 25/07/2024 10:30 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 26/07/2024 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
| 26/07/2024 10:30 am | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Immuneering Corporation
| 07/06/2024 12:27 pm | POLARIS GROUP: May 2024 Sales and Revenue Release |
| 30/05/2024 01:31 am | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
| 23/05/2024 04:30 pm | CUREVAC N.V.: Q1 2024 Earnings Release |
| 22/05/2024 10:30 am | EVOTEC SE: Q1 2024 Earnings Release |
| 22/05/2024 02:44 am | ALVOTECH: Q1 2024 Earnings Release |
| 21/05/2024 04:30 pm | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 17/05/2024 11:30 am | BIOARCTIC AB: Q1 2024 Earnings Release |
| 16/05/2024 01:35 am | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 15/05/2024 04:30 pm | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 15/05/2024 | GNI GROUP LTD.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- IMRX Stock
- Calendar Immuneering Corporation
